Related Experiment Video
Updated: Aug 13, 2026

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone
M G Mazzucconi1, M Peraino, L Bizzoni
1Hematology, Dipartimento di Biotecnologie Cellulari ed Ematologia, University 'La Sapienza' Rome, Italy.
Abstract:
The occurrence of acquired inhibitor against factor IX:C is infrequent in haemophilia B patients and is very rare in previously healthy subjects, in whom it is often related to underlying diseases. We describe the case of a 2-year-old girl, who was referred to our hospital with haematomas, without previous bleeding history. Prolonged APTT, normal PT and a factor IX:C level below 1% were found. An inhibitor against factor IX:C was detected (5.5 U mL(-1)). Her father and mother showed normal factor IX:C levels. Treatment with high-dose immunoglobulin (400 mg kg(-1) day(-1) for 5 consecutive days by intravenous infusion) and dexamethasone (4 mg three times a day by intravenous injection for 4 consecutive days) normalized factor IX:C levels and overcame the inhibitor. In conclusion, high-dose immunoglobulin and high-dose dexamethasone are a successful and safe immunosuppressive approach for recovery from inhibitor occurrence.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Respiratory Syncytial Virus Disease

